Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Off Label-use”

75 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 75 results

Large-scale testing (Phase 3)Study completedNCT00259272
What this trial is testing

Validation of Multidimensional Assessment of THYmic States (MATHYS): A Study in a Population of Bipolar Patients Treated With Olanzapine

Who this might be right for
Bipolar Disorder I or II
Eli Lilly and Company 141
Not applicableStudy completedNCT04565977
What this trial is testing

Evaluating Off-label Use of Direct Oral Anticoagulants (DOACs) in Hypercoagulable States

Who this might be right for
Hypercoagulable States
Methodist Health System 42
Large-scale testing (Phase 3)UnknownNCT00740571
What this trial is testing

Amitriptyline or Pregabalin to Treat Neuropathic Pain in Incurable Cancer

Who this might be right for
CancerNeuralgia
Radboud University Medical Center 130
Post-approval studies (Phase 4)UnknownNCT00468429
What this trial is testing

Subconjunctival Bevacizumab to Prevent Bleb Failure After Glaucoma Filtration Surgery

Who this might be right for
Glaucoma
Grewal Eye Institute 40
Very early researchStudy completedNCT01631331
What this trial is testing

Vismodegib in Treating Patients With Basal Cell Carcinoma (BCC)

Who this might be right for
Basal Cell Carcinoma of the SkinRecurrent Skin Cancer
Stanford University 15
Large-scale testing (Phase 3)Study completedNCT04347031
What this trial is testing

The Effectiveness of an Off Label Mefloquine Use for the Treatment of Patients With COVID19

Who this might be right for
Pneumonia, ViralRespiratory Failure
Burnasyan Federal Medical Biophysical Center 320
Not applicableUnknownNCT01101295
What this trial is testing

The ITP-RITUX Cohort: Rituximab in Immune ThrombocytoPenia.

Who this might be right for
Purpura, Thrombocytopenic, IdiopathicAutoimmune Thrombocytopenia
Henri Mondor University Hospital 250
Testing effectiveness (Phase 2)WithdrawnNCT05726682
What this trial is testing

Investigate Use of Off-the-shelf Natural Killer (NK) Cells (SAR445419) in Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Who this might be right for
Allogenic Stem Cell Transplantation
Sanofi
Testing effectiveness (Phase 2)Looking for participantsNCT06754098
What this trial is testing

Doxecitin and Doxribthymine in Adult Subjects With Thymidine Kinase 2 (TK2) Deficiency

Who this might be right for
Thymidine Kinase 2 (TK2 ) DeficiencyMitochondrial Myopathies
Cristina Domínguez González 15
Not applicableLooking for participantsNCT06724562
What this trial is testing

An Observational Pre-post Study to Observe if the Off Label Use of Anti-IL1 Therapies, Such as Anakinra or Canakinumab, Can Block ACVR1-induced Flare Activity and Heterotopic Ossification in FOP

Who this might be right for
Fibrodysplasia Ossificans Progressiva (FOP)
University of California, San Francisco 11
Not applicableStudy completedNCT02852590
What this trial is testing

Relationship Between Adverse Drug Reactions and Unlicensed/ Off-label Drug Use in Hospitalized Children

Who this might be right for
Hospitalized Children
Hospices Civils de Lyon 6,227
Not applicableStudy completedNCT02066805
What this trial is testing

Estimation of Off-Label Use of XGEVA® (Denosumab) Using Population-Based Databases in Denmark

Who this might be right for
XGEVA Off-label Use
Amgen 142
Not applicableStudy completedNCT03582072
What this trial is testing

CMO Letter to Reduce Unnecessary Antibiotic Prescribing March 2018

Who this might be right for
Prescribing, Off-Label
Public Health England 4,796
Not applicableLooking for participantsNCT04457713
What this trial is testing

Off-label Use of Anti-cancer Drugs in Norway -a Prospective Cohort Study

Who this might be right for
Cancer
Oslo University Hospital 200
Testing effectiveness (Phase 2)Study completedNCT00523354
What this trial is testing

Off Label Use of Infliximab in Adult Patients With Severe Eosinophilic Esophagitis

Who this might be right for
Esophagitis
Swiss EE Study Group
Not applicableStudy completedNCT00633945
What this trial is testing

Evaluation of Lenalidomide (REVLIMID®) to Treat Subjects With Cutaneous Lupus Erythematosus (CLE)

Who this might be right for
Cutaneous Lupus Erythematosus (CLE)
University of Pennsylvania 5
Not applicableUnknownNCT00403026
What this trial is testing

Intravitreal Bevacizumab for Retinal Disorders

Who this might be right for
Wet AMDMacular OedemaProliferative Diabetic Retinopathy
Narayana Nethralaya 150
Early research (Phase 1)UnknownNCT04554589
What this trial is testing

The Off Label Use of Glycopyrrolate in the Adults Intensive Care Unit.

Who this might be right for
Effect of Drugs
Tanta University 80
Not applicableEnrolling By InvitationNCT06585215
What this trial is testing

Standardization of Physician-Modified Stent Grafts for Abdominal Aortic Aneurysms

Who this might be right for
Abdominal Aortic AneurysmEndovascular ProceduresStents+1 more
Ente Ospedaliero Cantonale, Bellinzona 100
Testing effectiveness (Phase 2)Looking for participantsNCT06006143
What this trial is testing

Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 2

Who this might be right for
Alcohol Use DisorderHivTobacco Use Disorder
Yale University 30
Load More Results